Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Christopher G. Morris, MS"'
Autor:
Julie A. Bradley, MD, Xiaoying Liang, PhD, Raymond B. Mailhot Vega, MD, MPH, Chunbo Liu, PhD, Eric D. Brooks, MD, Teena Burchianti, ARNP, Emma Viviers, MS, Roi Dagan, MD, MS, Oluwadamilola T. Oladeru, MD, MA, MBA, Christopher G. Morris, MS, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 4, Pp 269-278 (2023)
Purpose: To determine the rib fracture rate in a cohort of patients with breast cancer treated with proton therapy. Patient and Methods: From a prospective database, we identified 225 patients treated with proton therapy between 2012 and 2020 (223 wo
Externí odkaz:
https://doaj.org/article/d3e5fc85fd7c428aadf2996f42a03e7b
Autor:
Michael S. Rutenberg, MD, PhD, Bradford S. Hoppe, MD, MPH, Jason S. Starr, DO, Ziad Awad, MD, Mathew Thomas, MBBS, MD, Christopher G. Morris, MS, Perry Johnson, PhD, Randal H. Henderson, MD, MBA, Jeremy C. Jones, MD, Bharatsinh Gharia, MBBS, MD, Steven Bowers, MD, Herbert C. Wolfsen, MD, Sunil Krishnan, MBBS, MD, Stephen J. Ko, MD, Hani M. Babiker, MD, Romaine C. Nichols, Jr, MD
Publikováno v:
International Journal of Particle Therapy, Pp 18-29 (2022)
Purpose: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation therapy allows a reduced radiation dose to both the hear
Externí odkaz:
https://doaj.org/article/6e0ce34c85cc410c8a3e146ab69d68ad
Autor:
James E. Bates, MD, Stephanie Terezakis, MD, Christopher G. Morris, MS, Avani D. Rao, MD, Shuchi Sehgal, BA, Rahul Kumar, MBBS, Raymond B. Mailhot Vega, MD, MPH, Nancy P. Mendenhall, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 21-27 (2021)
Purpose: Early stage (stages I-II) classical Hodgkin lymphoma (cHL) is a highly curable disease typically diagnosed in adolescents and young adults (AYAs). Proton therapy can also reduce the late toxicity burden in this population, but data on its co
Externí odkaz:
https://doaj.org/article/4662bd6f283b47d2addc8493de90f859
Autor:
Natalie A. Lockney, MD, Randal H. Henderson, MD, MBA, Steven G. Swarts, PhD, Zhenhuan Zhang, MD, PhD, Bingrong Zhang, DVM, MD, Jennifer Li, BS, Robert A. Zlotecki, MD, PhD, Christopher G. Morris, MS, Katherine A. Casey-Sawicki, MA, Paul G. Okunieff, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 28-35 (2021)
Background: After radiation therapy (RT), circulating plasma cell-free DNA (cfDNA) released in response to RT damage to tissue can be measured within hours. We examined for a correlation between cfDNA measured during the first week of therapy and ear
Externí odkaz:
https://doaj.org/article/6f789986096b4d19b2261b3f95ebd1cd
Autor:
William M. Mendenhall, MD, Eric D. Brooks, MD, MHS, Stephanie Smith, Christopher G. Morris, MS, Curtis B. Bryant, MD, MPH, Randal H. Henderson, MD, Romaine C. Nichols, Jr., MD, Kathy McIntyre, Stuart L. Klein, MHA, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 36-42 (2021)
Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials and Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended
Externí odkaz:
https://doaj.org/article/d56f508053b54ed0882190767981a28b
Autor:
Roi Dagan, MD, MS, Haruka Uezono, MD, Curtis Bryant, MD, Adam L. Holtzman, MD, Christopher G. Morris, MS, William M. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 200-212 (2021)
Purpose: To report long-term disease control, survival, and toxicity after proton therapy for sinonasal cancer. Patients and Methods: We reviewed 143 cases of adults with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant
Externí odkaz:
https://doaj.org/article/59928fbefea54bc899689b2377dcc556
Autor:
Adam L. Holtzman, MD, Ronny L. Rotondo, MD, Michael S. Rutenberg, MD, PhD, Daniel J. Indelicato, MD, Alexandra De Leo, MD, Dinesh Rao, MD, Jeet Patel, MD, Christopher G. Morris, MS, William M. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 179-188 (2021)
Purpose: To evaluate the effectiveness of external-beam proton therapy (PT) on local control and survival in patients with skull-base chordoma. Materials and Methods: We reviewed the medical records of patients with skull-base chordoma treated with d
Externí odkaz:
https://doaj.org/article/cd956fe89c3345049a68cfe17ded6b7f
Autor:
Shivam M. Kharod, MD, Catherine E. Mercado, MD, Christopher G. Morris, MS, Curtis M. Bryant, MD, MPH, Nancy P. Mendenhall, MD, William M. Mendenhall, MD, R. Charles Nichols, MD, Bradford S. Hoppe, MD, MPH, Xiaoying Liang, PhD, Zhong Su, PhD, Zuofeng Li, DSc, Randal H. Henderson, MD, MBA
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 4, Pp 52-64 (2021)
Purpose: Postprostatectomy radiation improves disease control, but limited data exist regarding outcomes, toxicities, and patient-reported quality of life with proton therapy. Method and Materials: The first 102 patients who were enrolled on an outco
Externí odkaz:
https://doaj.org/article/8f335a2fb6b5444383014baf7ca5424e
Autor:
Shivam M. Kharod, MD, R.Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD, Vandana K. Seeram, MBBS, Lisa M. Jones, MD, Maria Antonio-Miranda, MD, Daniel A. Siragusa, MD, Zuofeng Li, DSc, Stella Flampouri, PhD, MSc, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 2, Pp 1-10 (2020)
Purpose: Due to the excellent outcomes with image-guided stereotactic body radiotherapy for patients with early-stage non–small cell lung cancer (NSCLC) and the low treatment-related toxicities using proton therapy (PT), we investigated treatment o
Externí odkaz:
https://doaj.org/article/be204a5aa19b43449b4e30ecf3ffe4a1
Autor:
Natalie A. Lockney, MD, Randal Henderson, MD, Steven G. Swarts, PhD, Zhenhuan Zhang, MD, PhD, Bingrong Zhang, DVM, MD, Jennifer Li, BS, Robert A. Zlotecki, MD, PhD, Christopher G. Morris, MS, Katherine Casey-Sawicki, MA, Paul Okunieff, MD
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 2, Pp 21-30 (2020)
Purpose: The RadTox assay measures circulating cell-free DNA released in response to radiotherapy (RT)-induced tissue damage. The primary objectives for this clinical trial were to determine whether cell-free DNA numbers measured by the RadTox assay
Externí odkaz:
https://doaj.org/article/e5d4ac6a56614569bfd5b8b8545a69f9